JAYSYNTH ORGOCHEM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.64 INR | +1.98% |
|
+22.68% | +218.24% |
| Jul. 03 | JD Orgochem Limited has Changed its Name to Jaysynth Orgochem Limited | CI |
| May. 29 | JD Orgochem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 55.38 | 32.99 | 31.93 | 42.53 | 70.09 | 57.5 |
| Enterprise Value (EV) 1 | 216.5 | 193.2 | 211.2 | 228.3 | 261.4 | 349.5 |
| P/E ratio | -132 x | 1.92 x | -2.8 x | -4.99 x | -6.12 x | -0.89 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 4.62 x | 1.85 x | 2.13 x | 3.45 x | 4.79 x | 5.84 x |
| EV / Revenue | 18 x | 10.8 x | 14.1 x | 18.5 x | 17.9 x | 35.5 x |
| EV / EBITDA | -57 x | 8.16 x | -70.2 x | 114 x | -82.6 x | -59.6 x |
| EV / FCF | 125 x | 8.64 x | -15.4 x | 595 x | 699 x | -22.3 x |
| FCF Yield | 0.8% | 11.6% | -6.5% | 0.17% | 0.14% | -4.48% |
| Price to Book | -0.3 x | -0.2 x | -0.18 x | -0.23 x | -0.36 x | -0.22 x |
| Nbr of stocks (in thousands) | 13,250 | 13,250 | 13,250 | 13,250 | 13,250 | 13,250 |
| Reference price 2 | 4.180 | 2.490 | 2.410 | 3.210 | 5.290 | 4.340 |
| Announcement Date | 9/1/18 | 8/21/19 | 9/3/20 | 9/1/21 | 7/14/22 | 8/30/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 12 | 17.88 | 15.02 | 12.32 | 14.62 | 9.84 |
| EBITDA 1 | -3.799 | 23.67 | -3.007 | 2 | -3.165 | -5.869 |
| EBIT 1 | -10.83 | 16.64 | -10.03 | -6.25 | -10.19 | -7.702 |
| Operating Margin | -90.22% | 93.08% | -66.82% | -50.73% | -69.71% | -78.27% |
| Earnings before Tax (EBT) 1 | -0.417 | 17.2 | -10.71 | -8.521 | -11.45 | -64.91 |
| Net income 1 | -0.4208 | 17.2 | -11.4 | -8.521 | -11.45 | -64.91 |
| Net margin | -3.51% | 96.21% | -75.93% | -69.16% | -78.33% | -659.61% |
| EPS 2 | -0.0318 | 1.298 | -0.8604 | -0.6431 | -0.8643 | -4.899 |
| Free Cash Flow 1 | 1.732 | 22.35 | -13.73 | 0.384 | 0.3738 | -15.67 |
| FCF margin | 14.44% | 125.03% | -91.41% | 3.12% | 2.56% | -159.3% |
| FCF Conversion (EBITDA) | - | 94.45% | - | 19.2% | - | - |
| FCF Conversion (Net income) | - | 129.95% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/1/18 | 8/21/19 | 9/3/20 | 9/1/21 | 7/14/22 | 8/30/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 161 | 160 | 179 | 186 | 191 | 292 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -42.41 x | 6.77 x | -59.63 x | 92.87 x | -60.43 x | -49.75 x |
| Free Cash Flow 1 | 1.73 | 22.4 | -13.7 | 0.38 | 0.37 | -15.7 |
| ROE (net income / shareholders' equity) | 0.23% | -9.9% | 6.67% | 4.71% | 5.98% | 28.3% |
| ROA (Net income/ Total Assets) | -8.24% | 13.5% | -9.08% | -6.39% | -11.9% | -10% |
| Assets 1 | 5.11 | 127.6 | 125.5 | 133.4 | 95.92 | 649.3 |
| Book Value Per Share 2 | -13.80 | -12.50 | -13.30 | -14.00 | -14.90 | -19.80 |
| Cash Flow per Share 2 | 0.1300 | 0.2000 | 0.1600 | 0.1100 | 0.2500 | 0.1800 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 9/1/18 | 8/21/19 | 9/3/20 | 9/1/21 | 7/14/22 | 8/30/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +218.24% | 34.3M | |
| +22.13% | 69.36B | |
| -5.88% | 46.25B | |
| +25.49% | 44.28B | |
| +39.18% | 28.85B | |
| +14.24% | 20.17B | |
| +14.21% | 17.19B | |
| -27.30% | 14.95B | |
| -15.43% | 14.63B | |
| -33.19% | 11.85B |
- Stock Market
- Equities
- JDORGOCHEM6 Stock
- Financials Jaysynth Orgochem Limited
